Conmed (CNMD) Income towards Parent Company (2010 - 2026)

Conmed (CNMD) has reported Income towards Parent Company for 17 consecutive years, with $23.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Income towards Parent Company rose 7.7% year-over-year to $23.1 million; the trailing twelve-month figure through Jun 2026 stood at $56.5 million (down 48.73% YoY), and the FY2025 full-year result was $47.1 million, down 64.47% from the prior year.
• Income towards Parent Company grew to $23.1 million in Q2 2026 per CNMD's latest filing, from $13.8 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at $49.0 million in Q3 2024 and bottomed at -$168.3 million in Q2 2022.
• Historically, Income towards Parent Company has averaged $11.1 million across 5 years, with a median of $18.2 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Income towards Parent Company sank 1366.3% in 2022, then soared 983.51% in 2024.
• Over 5 years, Income towards Parent Company stood at $26.6 million in 2022, then grew by 24.4% to $33.1 million in 2023, then grew by 2.07% to $33.8 million in 2024, then plunged by 50.41% to $16.7 million in 2025, then soared by 37.83% to $23.1 million in 2026.
• According to Business Quant data, Income towards Parent Company over the past three periods registered $23.1 million, $13.8 million, and $16.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.